atenolol has been researched along with Asystole in 18 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "0 h after the onset of suspected acute myocardial infarction were randomised either to a control group or to a group receiving atenolol (5-10 mg iv immediately, followed by 100 mg/day orally for 7 days)." | 9.06 | Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. ( , 1986) |
| "0 h after the onset of suspected acute myocardial infarction were randomised either to a control group or to a group receiving atenolol (5-10 mg iv immediately, followed by 100 mg/day orally for 7 days)." | 5.06 | Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group. ( , 1986) |
| "A case on concomitant atenolol-verapamil therapy for hypertension and angina pectoris, developing sinus arrest and life-threatening bradycardia is described." | 3.67 | Sinus arrest caused by atenolol-verapamil combination. ( Bhandari, K; Misra, M; Thakur, R, 1987) |
| "Atenolol was the beta-blocker most used." | 2.55 | Beta-blockers for hypertension. ( Bradley, HA; Mayosi, BM; Opie, LH; Volmink, J; Wiysonge, CS, 2017) |
| "Initiating treatment of hypertension with beta-blockers leads to modest reductions in cardiovascular disease and no significant effects on mortality." | 2.48 | Beta-blockers for hypertension. ( Bradley, HA; Mayosi, BM; Mbewu, A; Opie, LH; Volmink, J; Wiysonge, CS, 2012) |
| "Two patients with hypertrophic cardiomyopathy are reported from the recent experience of the Hypertrophic Cardiomyopathy Center of the Minneapolis Heart Institute Foundation, demonstrating limitations in the risk stratification algorithm currently used for this disease." | 1.35 | Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status. ( Appelbaum, E; Haas, TS; Harrigan, CJ; Hauser, RG; Lesser, JR; Main, ML; Maron, BJ; Maron, MS; Roberts, WC, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (16.67) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 6 (33.33) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cafferkey, A | 1 |
| McMahon, C | 1 |
| Abu-Zeitone, A | 1 |
| Peterson, DR | 1 |
| Polonsky, B | 1 |
| McNitt, S | 1 |
| Moss, AJ | 1 |
| Wiysonge, CS | 2 |
| Bradley, HA | 2 |
| Volmink, J | 2 |
| Mayosi, BM | 2 |
| Opie, LH | 2 |
| Xanthos, T | 1 |
| Bassiakou, E | 1 |
| Koudouna, E | 1 |
| Rokas, G | 1 |
| Goulas, S | 1 |
| Dontas, I | 1 |
| Kouskouni, E | 1 |
| Perrea, D | 1 |
| Papadimitriou, L | 1 |
| Mbewu, A | 1 |
| Ishiyama, T | 1 |
| Oguchi, T | 1 |
| Yamaguchi, T | 1 |
| Kumazawa, T | 1 |
| Bonvini, RF | 1 |
| Hendiri, T | 1 |
| Anwar, A | 1 |
| Maron, BJ | 1 |
| Maron, MS | 1 |
| Lesser, JR | 1 |
| Hauser, RG | 1 |
| Haas, TS | 1 |
| Harrigan, CJ | 1 |
| Appelbaum, E | 1 |
| Main, ML | 1 |
| Roberts, WC | 1 |
| Roach, PJ | 1 |
| Magee, MA | 1 |
| Freedman, SB | 1 |
| Arad, M | 1 |
| Solomon, A | 1 |
| Roth, A | 1 |
| Atsmon, J | 1 |
| Rabinowitz, B | 1 |
| Adams, JN | 1 |
| Denver, MA | 1 |
| Rae, AP | 1 |
| Snook, CP | 1 |
| Sigvaldason, K | 1 |
| Kristinsson, J | 1 |
| Slater, TW | 1 |
| Stinson, J | 1 |
| Walsh, M | 1 |
| Feely, J | 1 |
| Saitz, R | 1 |
| Williams, BW | 1 |
| Farber, HW | 1 |
| Partanen, J | 1 |
| Pellinen, TJ | 1 |
| Misra, M | 1 |
| Thakur, R | 1 |
| Bhandari, K | 1 |
2 reviews available for atenolol and Asystole
| Article | Year |
|---|---|
Beta-blockers for hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; | 2017 |
Beta-blockers for hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Antihypertensive Agents; | 2012 |
1 trial available for atenolol and Asystole
| Article | Year |
|---|---|
Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
Topics: Administration, Oral; Age Factors; Aged; Atenolol; Cardiotonic Agents; Clinical Trials as Topic; Dru | 1986 |
15 other studies available for atenolol and Asystole
| Article | Year |
|---|---|
Successful Treatment of Refractory Cardiac Arrest With β-Blockade and Extracorporeal Life Support in a Pediatric Patient With Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolo | 2018 |
Efficacy of different beta-blockers in the treatment of long QT syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Child; Child, Preschool; Death, Sudden, Ca | 2014 |
Combination pharmacotherapy in the treatment of experimental cardiac arrest.
Topics: Adrenergic beta-Agonists; Animals; Atenolol; Cardiotonic Agents; Disease Models, Animal; Drug Therap | 2009 |
Sinus node dysfunction associated with discontinuation of cilostazol in a patient taking atenolol.
Topics: Adrenergic beta-Antagonists; Aged; Atenolol; Cilostazol; Heart Arrest; Humans; Intraoperative Compli | 2004 |
Sinus arrest and moderate hyperkalemia.
Topics: Antihypertensive Agents; Arrhythmia, Sinus; Atenolol; Biphenyl Compounds; Bradycardia; Depression, C | 2006 |
Sudden cardiac arrest in hypertrophic cardiomyopathy in the absence of conventional criteria for high risk status.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Atenolol; Cardiomyopathy, Hypertrophic; Defibrillato | 2008 |
Asystole and bradycardia during dipyridamole stress testing in patients receiving beta blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Bradycardia; Dipyridamole; Electrocardiography; Exercise Test | 1993 |
Postexercise syncope: evidence for increased activity of the sympathetic nervous system.
Topics: Adult; Arousal; Atenolol; Bradycardia; Epinephrine; Exercise Test; Heart Arrest; Humans; Hypertensio | 1993 |
Coronary artery spasm leading to life threatening arrhythmias.
Topics: Adrenergic beta-Antagonists; Adult; Arrhythmias, Cardiac; Atenolol; Calcium Channel Blockers; Contra | 1998 |
Severe atenolol and diltiazem overdose.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Calcium Channel Blockers; Diltiazem; Drug Interactions | 2000 |
A 39-year-old man with an overdose of beta-blockers.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Atenolol; Drug Overdose; Electrocardio | 2001 |
Ventricular asystole and overdose with atenolol.
Topics: Adult; Atenolol; Drug Overdose; Fluid Therapy; Heart Arrest; Humans; Male; Pacemaker, Artificial | 1992 |
Atenolol-induced cardiovascular collapse treated with hemodialysis.
Topics: Atenolol; Heart Arrest; Humans; Male; Middle Aged; Poisoning; Renal Dialysis | 1991 |
Diltiazem and sinus arrest in connection with atenolol and digoxin.
Topics: Atenolol; Cardiovascular Agents; Drug Administration Schedule; Drug Therapy, Combination; Heart Arre | 1989 |
Sinus arrest caused by atenolol-verapamil combination.
Topics: Adult; Atenolol; Bradycardia; Drug Synergism; Drug Therapy, Combination; Electrocardiography; Heart | 1987 |